A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism

Daniel J. Daugherty(Salk Institute for Biological Studies), David Schubert(Institute of Cell Biology and Neurobiology)
Alzheimer s Research & Therapy
July 14, 2017
Cited by 41


Related Papers